The company also added former FDA official Marianne Mann and former Merck & Co...XOMA Ltd., of Berkeley, Calif., appointed Fred Kurland vice president of finance and chief financial officer

and Steve Neben senior director of project and alliance management...Oxigene Inc., of Waltham, Mass., named Nicole Onetto and Eric K. Rowinsky to the board of its subsidiary Symphony ViDA Inc

TyRx Inc., of Monmouth Junction, N.J., appointed William G. Dempsey an independent director. Vitae Pharmaceuticals Inc., of Fort Washington, Pa., promoted Tina Fiumenero to chief financial officer. XOMA Ltd., of Berkeley, Calif., appointed Stephen K. Doberstein vice president of research.

Prognostix Inc., of Cleveland, appointed Jake Orville president and CEO...Thomas Hecht was appointed chairman, and Michael Motschmann will join the board...SuppreMol also named Fritz Melchers and Falk Nimmerjahn to its scientific advisory board

ImmunoGen Inc., of Waltham, Mass., appointed James J. O'Leary vice president and chief medical officer...Infinity Pharmaceuticals Inc., of Cambridge, Mass., promoted Adelene Q. Perkins president and chief business officer...It also appointed Bruce R. Thaw chairman and named James E. Rothman chairman of the scientific advisory board

The company appointed Craig A. Collard president and CEO and named Alastair McEwan chairman...It also appointed Christopher Codeanne, Michael Enright and Michael Heffernan to the board

Bioheart Inc., of Sunrise, Fla., appointed Matt Fendrich vice president of sales and marketing and named Alan P. Timmins to the board...Biovail Corp., of Toronto, appointed H. Christian Fibiger senior vice president and chief scientific officer of Biovail Laboratories International SRL...BioXcel Corp., of New Haven, Conn., added R. Christopher Seaton, Martha Matteo and Kevin Rakin to its corporate advisory board

AAIPharma, of Wilmington, N.C., appointed Andreas Dreps senior vice president of global clinical development services and named Ralf Wolter vice president of clinical operations, Europe...Adimab Inc., of Lebanon, N.H., appointed Guy Van Meter senior director and head of business development...Antisoma plc, of London, appointed Eric Dodd chief financial officer and board member

UCB SA, of Brussels, Belgium, appointed Michele Antonelli executive vice president of technical operations and quality assurance and named Mark McDade executive vice president of global operations

Quinnova Pharmaceuticals Inc., of Newtown, Pa., appointed Christopher Hensby senior vice president of research and development...Seattle Genetics Inc., of Bothell, Wash., named Elaine Waller senior vice president of regulatory affairs and appointed Christopher Pawlowicz senior vice president of human resources...Somnus Therapeutics Inc., of Bedminster, N.J., appointed Gary Cupit, Linda C. Hogan, David Ramsay and Jack W. Britts to its board

It also named Chas Bountra as chairman and Annette Dolphin to its scientific advisory board...and Faith Pomeroy-Ward as executive director of investor relations and corporate communications

Prometheus Laboratories Inc., of San Diego, named Mark Spring senior vice president and chief financial officer...Targanta Therapeutics Corp., of Cambridge, Mass., appointed Stéphane Bancel and Rosemary A. Crane to its board...Trubion Pharmaceuticals Inc., of Seattle, appointed Scott C. Stromatt senior vice president and chief medical officer

Tengion Inc., of East Norriton, Pa., named Mark Stejbach vice president of marketing and commercial planning...TheraGenetics Ltd., of Cambridge, Mass., and London, appointed Susan E. Bromley global head of R&D and named Kenneth B. Milne UK director of R&D

PolyMedix Inc., of Radnor, Pa., elected Richard Bank and Stefan Loren to its board...PPD Inc., of Wilmington, N.C., appointed Christine Dingivan executive vice president and chief medical officer

Alverix Inc., of San Jose, Calif., named James D. Merselis president and CEO, and a member of the board of directors...Amsterdam Molecular Therapeutics, of Amsterdam, the Netherlands, appointed Janneke de Wal director global marketing and sales

David Mitchell senior director of regulatory affairs and quality assurance...and Jay Rheingold vice president of chemistry, manufacturing and controls

Alpharma Inc., of Bridgewater, N.J., appointed Ron Warner executive vice president and chief scientific officer and named R. Scott Shively senior vice president of pharmaceutical commercial operations...Althea Technologies Inc., of San Diego, named E. J. Brandreth vice president of quality and regulatory

Javelin Pharmaceuticals Inc., of Cambridge, Mass., named Daniel Carr president and said Fred Mermelstein assumed the role of executive director...Oncothyreon Inc., of Bellevue, Wash., named Daniel K. Spiegelman and Stephen K. Burley to its board...Pantec Biosolutions AG, of Ruggell, Leichtenstein, appointed Burkhard Feurstein and Michael Armbruester to its board

Adolor Corp., of Exton, Pa., promoted Lee Techner to vice president of medical affairs and medical director...It also named Guido Magni to its board and the governance and nominating committee